Correction to Supplement 2: Misspelling of a Collaborator’s Name

October 19, 2026

Jama Network Open

Overview

A correction notice addresses a misspelling of nonauthor collaborator Ahmet Bulent Dogrul’s name in Supplement 2 of the Original Investigation “Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms.” The investigation was published March 27, 2026; the supplied notice does not describe changes to its scientific content.

Background

Correction notices document amendments to the published record, including errors in collaborator names, author names, figures, and online or print versions. The supplied related notices describe corrections to names and figure presentation in articles across several clinical fields. The focal notice concerns Supplement 2 of an investigation on adjuvant chemotherapy for intraductal papillary mucinous neoplasms (IPMNs). The provided correction information does not report chemotherapy outcomes or other clinical data from that investigation.

Data Highlights

The supplied correction notice reports a name-spelling amendment only; it provides no numerical or trial data.

Key Findings

Supplement 2 contained a misspelling of nonauthor collaborator Ahmet Bulent Dogrul’s name.
The correction concerns the Original Investigation “Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms,” published March 27, 2026.
A related Bone Marrow Transplantation notice corrected the spelling of an author’s surname from “Niederwiser” to “Niederwieser” and noted that Figure 2 had been submitted twice, with the published Figure 3 incorrect.
A 2016 BMC Infectious Diseases correction clarified the given and family name structure for Chen Namimi-Halevi.
A related Acta Neurochirurgica erratum reported an incorrect collaborator surname in the HTML version and a collaborator name omitted from that version but present in the PDF.

Clinical Implications

The focal notice identifies a collaborator-name correction and does not report a change to clinical findings, treatment recommendations, or patient care. The supplied material does not provide further clinical implications of this amendment.

Conclusion

The correction updates the spelling of a nonauthor collaborator’s name in Supplement 2. No scientific or clinical changes are described in the supplied notice.